Coverage dated December 29, 2021 to December 30, 2021
FDA set to open Pfizer boosters to some youths
Headline from Arkansas Democrat-Gazette
The Food and Drug Administration is planning to broaden eligibility for coronavirus vaccine booster doses Monday, allowing 12- to 15-year-olds to receive third doses of Pfizer-BioNTech's vaccine, according to people familiar with the agency's deliberations.
Arkansas Democrat-Gazette's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
New U.S. data based on nearly 9 million doses of the Pfizer-BioNTech COVID-19 vaccine delivered to kids ages 5 to 11 shows no major safety issues, according to researchers at the U.S. Centers for Disease Control and Prevention.
The U.S. Food and Drug Administration is expected to broaden eligibility for Pfizer COVID-19 vaccine boosters to youths ages 12 to 15 in the coming days, according to a person
The Food and Drug Administration (FDA) is expected to approve booster shots of Pfizer and BioNTech's COVID-19 for 12- to 15-year-olds on Monday, people familiar with the agency's plan told
THURSDAY, Dec. 30, 2021 (HealthDay News) -- New U.S. data based on nearly 9 million doses of the Pfizer-BioNTech COVID-19 vaccine delivered to kids ages 5 to 11 shows no
The Food and Drug Administration is expected by early next week to authorize booster shots of the Pfizer-BioNTech coronavirus vaccine for 12- to 15-year-olds, according to two people familiar with the FDA's plan.
The Food and Drug Administration is planning to broaden eligibility for coronavirus vaccine booster doses Monday, allowing 12- to 15-year-olds to receive third doses of Pfizer-BioNTech's vaccine, according to people familiar with the agency's deliberations.
The Food and Drug Administration is expected by early next week to authorize booster shots of the Pfizer-BioNTech coronavirus vaccine for 12- to 15-year-olds, according to two people familiar with
